Manufacturing counterfeit drugs and falsifying or tampering with the labels of medical products are serious violations of the law, which not only endanger public health, but also face severe legal sanctions. The following is the relevant analysis： --- ### **1. Technical feasibility** -**Difficulty of label forgery**: Modern pharmaceutical labels usually contain complex anti-counterfeiting technologies (such as holograms, serial numbers, invisible inks, blockchain traceability codes, etc.), which are difficult for ordinary people to copy perfectly. Tampering with the expiration date or batch number may be detected by professional equipment. -**Threshold for the production of counterfeit drugs**: Counterfeit drugs may use invalid ingredients (such as starch) or toxic substances, but production needs to avoid supervision and imitate the appearance of drugs (such as tablet color and packaging material), which is very challenging for non-professionals. --- ### **2. Cost and risk** -**The cost may not be lower**: Although the ingredients of counterfeit drugs are cheap, the cost of falsifying high-quality labels, establishing distribution channels, and evading regulation may be higher than expected. Once seized, legal penalties and reputational losses far exceed short-term gains. -**Legal risks**: Globally, the manufacture and sale of counterfeit drugs is a felony. For example, in China, according to Article 141 of the Criminal Law, the maximum sentence is life imprisonment or death, and a fine or confiscation of property. --- ### **3. Health and social hazards** -**Direct threat to life**: Counterfeit drugs may cause delays in treatment, drug poisoning, or increased drug resistance. For example, fake anti-cancer drugs or antibiotics may directly cause death. -**Destruction of medical trust**: The proliferation of counterfeit drugs will weaken public confidence in the medical system and hinder the research and development and circulation of legal drugs. --- ### **4. Supervision and means of combating** - **Global collaboration**: International organizations (such as WHO, INTERPOL) and national drug regulatory departments (such as FDA, NMPA) continue to combat counterfeit drugs and increase the seizure rate through technical means (blockchain, big data tracking). -**Consumer awareness raising**: The public can verify medicines through official channels (such as scanning traceability codes) and report suspicious products. --- ###**How to protect yourself? ** -**Purchase medicines from formal channels**: hospitals, pharmacies or authorized e-commerce platforms. -**Check the integrity of the packaging**: Pay attention to whether the printing quality, batch number, and expiration date of the label are abnormal. -**Use official tools**: Verify the authenticity of drugs through the website or APP of the drug administration department. --- ###**Conclusion** Although technical means may make counterfeiting seem "feasible”, the legal, ethical, and health risks far outweigh the short-term benefits. Society needs to jointly curb counterfeit drugs through severe legal punishment, technological innovation and public education, while individuals should be vigilant and refuse to purchase drugs of unknown origin. (Note: This article aims to objectively analyze the problem and resolutely oppose all illegal acts. ）